News Daily News Inactivity Pandemic Poised to Undo CVD Prevention Advances Michael O'Riordan April 11, 2023
News Daily News Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest Caitlin E. Cox April 11, 2023
News Daily News Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI Michael O'Riordan March 31, 2023
News Daily News MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter Yael L. Maxwell March 27, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Conference News ACC 2023 Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR Michael O'Riordan March 13, 2023
News Conference News ACC 2023 MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis Michael O'Riordan March 10, 2023
News Conference News ACC 2023 ‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk Caitlin E. Cox March 10, 2023
News Conference News ACC 2023 Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2 Michael O'Riordan March 09, 2023
News Conference News ACC 2023 No Downside to Immediate Complete Revascularization in ACS: BIOVASC Michael O'Riordan March 06, 2023
News Daily News Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL Michael O'Riordan February 15, 2023
News Daily News Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years L.A. McKeown February 13, 2023
News Daily News Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults Michael O'Riordan February 09, 2023
News Daily News UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy Michael O'Riordan January 20, 2023
News Daily News CT Angiography Is Increasing in England, but Downstream Tests Are Not Michael O'Riordan January 12, 2023
News Daily News Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men Michael O'Riordan January 10, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023